Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). Amedisys's share price for the quarter that ended in Mar. 2024 was €84. Amedisys's Shares Outstanding (EOP) for the quarter that ended in Mar. 2024 was 33 Mil. Therefore, Amedisys's market cap for the quarter that ended in Mar. 2024 was €2,745 Mil.
Amedisys's quarterly market cap
declined
from Sep. 2023 (€2,839 Mil) to Dec. 2023 (€2,760 Mil) and
declined
from Dec. 2023 (€2,760 Mil) to Mar. 2024 (€2,745 Mil).
Amedisys's annual market cap
declined
from Dec. 2021 (€4,616 Mil) to Dec. 2022 (€2,504 Mil) but then
increased
from Dec. 2022 (€2,504 Mil) to Dec. 2023 (€2,760 Mil).
Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Amedisys's Enterprise Value for Today is €3,244 Mil.
Amedisys Market Cap Historical Data
The historical data trend for Amedisys's Market Cap can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Care Facilities subindustry, Amedisys's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Amedisys's Market Cap Distribution in the Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Amedisys's Market Cap distribution charts can be found below:
* The bar in red indicates where Amedisys's Market Cap falls into.
Amedisys Market Cap Calculation
Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.
Amedisys's Market Cap for the fiscal year that ended in Dec. 2023 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Amedisys (STU:ADY) Market Cap Explanation
Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.
Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.
Amedisys Market Cap Related Terms
Thank you for viewing the detailed overview of Amedisys's Market Cap provided by GuruFocus.com. Please click on the following links to see related term pages.
Amedisys Inc is a healthcare services company in the United States. The company brings healthcare to the home through the provision of home healthcare services, hospice services, high acuity care segment, and personal care services. The Home Health Segment provides skilled nurses, therapists, and aids to patients' homes throughout the United States, Hospice segment operates many centers designed to provide comfort and support for terminally ill patients, Personal Care Segment provides individuals with assistance in their daily living activities and High acuity care segment can deliver the essential elements of inpatient hospital, SNF care, and palliative care to patients in their homes. A majority of the company's revenue is derived from the Home Health segment.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
STU:ADY has been successfully added to your 